BioCentury
ARTICLE | Company News

Novartis sales and marketing update

February 1, 2016 8:00 AM UTC

The U.K.’s NICE issued final guidance recommending Farydak panobinostat from Novartis to treat multiple myeloma (MM) in patients who have received two prior therapies, including Velcade bortezomib a...